Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|July 23, 2021
Raman analysis of microcalcifications in male breast cancerAlessandro Caldarone, Francesca Piccotti, Carlo Morasso, et al.
Cancers|November 11, 2022
Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyMarta Truffi, Federico Sottotetti, Nadav Gafni, et al.
BMC Public Health|July 3, 2026
Early-onset cancer and modifiable risk: quantifying the combined impact of excess body weight and alcohol on breast and colorectal cancer in Italy (18-34 years)Federica Bolpagni, Simone Lanati, Ginevra Biino, et al.
Breast Cancer Research and Treatment|December 22, 2021
Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)Carlo Morasso, Alessandra Ricciardi, Daisy Sproviero, et al.
Therapeutic Advances in Medical Oncology|June 19, 2019
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experienceRaffaella Palumbo, Federico Sottotetti, Erica Quaquarini, et al.
Drugs in Context|June 28, 2023
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR<sup>+</sup>/HER2<sup>-</sup> breast cancer treated with CDK4/6 inhibitors and endocrine therapyBarbara Tagliaferri, Ludovica Mollica, Raffella Palumbo, et al.
Thoracic Cancer|September 2, 2022
Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experienceFrancesco Falanga, Pietro Rinaldi, Cristiano Primiceri, et al.
Drug Design, Development and Therapy|May 2, 2015
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of lifeRaffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò, et al.
Drugs in Context|November 7, 2022
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature reviewAnnalisa Schiepatti, Andrea Premoli, Stiliano Maimaris, et al.
Anticancer Research|December 29, 2010
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liverGuido Poggi, Emma Pozzi, Alberto Riccardi, et al.
Pageof 5